Thomas Eastling - Director at Gyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
GYRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Eastling since 4/19/2024

Holdings reported by Thomas Eastling for Gyre Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 15K $104K $6.93 Apr 16, 2025 Direct
Stock Option (Right to Buy) 300K Apr 16, 2025 Direct Common Stock

Transactions reported by Thomas Eastling for Gyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.